Intellia Therapeutics (NTLA) Gains from Investment Securities (2015 - 2025)
Intellia Therapeutics (NTLA) reported Gains from Investment Securities of $5.2 million for Q4 2025, up 271.09% year-over-year from $1.4 million in Q4 2024, and up 560.0% on a QoQ basis from $783901.0 in Q3 2025.
Intellia Therapeutics (NTLA) has 11 years of Gains from Investment Securities data on file, last reported at $5.2 million in Q4 2025.
- Quarterly Gains from Investment Securities rose 271.09% year-over-year to $5.2 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$3.0 million (down 51.5% YoY) and the FY2025 annual result came in at $5.2 million, up 963.21% from the prior year.
- Gains from Investment Securities climbed to $5.2 million in Q4 2025 per NTLA's latest filing, from $783901.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $171.3 million in Q3 2021 and bottomed at -$3.0 million in Q4 2024.
- The 5-year median for Gains from Investment Securities is $1.3 million (2022), against an average of $18.7 million.
- The widest annual swing landed in 2021, when Gains from Investment Securities jumped 18933.33%; it then tumbled 1658.14% in 2024.
- Tracing NTLA's Gains from Investment Securities over 5 years: stood at $171.3 million in 2021, then slumped by 60.95% to $66.9 million in 2022, then plunged by 100.26% to -$172000.0 in 2023, then plunged by 1658.14% to -$3.0 million in 2024, then jumped by 271.09% to $5.2 million in 2025.
- Per Business Quant, the three latest NTLA Gains from Investment Securities figures stand at $5.2 million (Q4 2025), $783901.0 (Q3 2025), and -$3.0 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Intellia Therapeutics | 1.63 Bn | 1.63 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.17 Mn |
| Dec 31, 2025 | 5.17 Mn |
| Sep 30, 2025 | 783,901.00 |
| Sep 30, 2025 | 783,901.00 |
| Dec 31, 2024 | -3.02 Mn |
| Dec 31, 2024 | -3.02 Mn |
| Sep 30, 2024 | 3.33 Mn |
| Sep 30, 2024 | 3.33 Mn |
| Jun 30, 2024 | 3.04 Mn |
| Jun 30, 2024 | 3.04 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Dec 31, 2023 | -172,000.00 |
| Dec 31, 2023 | -172,000.00 |
| Sep 30, 2023 | 181,743.00 |
| Sep 30, 2023 | 181,743.00 |
| Mar 31, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Dec 31, 2022 | 66.89 Mn |
| Dec 31, 2022 | 66.89 Mn |
| Sep 30, 2022 | 1.40 Mn |
| Sep 30, 2022 | 1.40 Mn |
| Jun 30, 2022 | 10.50 Mn |
| Jun 30, 2022 | 10.50 Mn |
| Mar 31, 2022 | 421,000.00 |
| Mar 31, 2022 | 421,000.00 |
| Sep 30, 2021 | 171.30 Mn |
| Sep 30, 2021 | 171.30 Mn |
| Dec 31, 2020 | -1.70 Mn |
| Dec 31, 2020 | -1.70 Mn |
| Sep 30, 2020 | 900,000.00 |
| Sep 30, 2020 | 900,000.00 |
| Jun 30, 2020 | 500,000.00 |
| Jun 30, 2020 | 500,000.00 |
| Mar 31, 2020 | 300,000.00 |
| Mar 31, 2020 | 300,000.00 |
| Dec 31, 2019 | 700,000.00 |
| Dec 31, 2019 | 700,000.00 |
| Sep 30, 2019 | 200,000.00 |
| Sep 30, 2019 | 200,000.00 |
| Jun 30, 2019 | 282,108.00 |
| Jun 30, 2019 | 282,108.00 |
| Mar 31, 2019 | 100,000.00 |
| Mar 31, 2019 | 100,000.00 |
| Dec 31, 2018 | 17.98 Mn |
| Dec 31, 2018 | 17.98 Mn |
| Sep 30, 2018 | 547,529.00 |
| Sep 30, 2018 | 547,529.00 |
| Jun 30, 2018 | 998,286.00 |
| Jun 30, 2018 | 998,286.00 |
| Mar 31, 2018 | 17,224.00 |
| Mar 31, 2018 | 17,224.00 |
| Dec 31, 2017 | -54,000.00 |
| Dec 31, 2017 | -54,000.00 |
| Sep 30, 2017 | 1.69 Mn |
| Sep 30, 2017 | 1.69 Mn |
| Jun 30, 2017 | 38,818.00 |
| Jun 30, 2017 | 38,818.00 |
| Mar 31, 2017 | 4.37 Mn |
| Mar 31, 2017 | 4.37 Mn |
| Dec 31, 2016 | -11,000.00 |
| Dec 31, 2016 | -11,000.00 |
| Sep 30, 2016 | 2.58 Mn |
| Sep 30, 2016 | 2.58 Mn |
| Jun 30, 2016 | 2.93 Mn |
| Jun 30, 2016 | 2.93 Mn |
| Mar 31, 2016 | 2.16 Mn |
| Mar 31, 2016 | 2.16 Mn |
| Dec 31, 2015 | -2,000.00 |
| Dec 31, 2015 | -2,000.00 |